Skip to main content
SpringerLink
Log in

Growth responses during the first year of growth hormone therapy: evaluation of height velocity targets

  • Practice Point
  • Published:

From Nature Clinical Practice Endocrinology & Metabolism

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ranke MB et al (1999) Derivation and validation of a mathematical model for predicting the response to exogenous recombinant growth hormone (GH) in prebubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. J Clin Endocrinol Metab 84: 1174–1183

    Article  CAS  Google Scholar 

  2. Schönau E et al. (2001) A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency. Eur J Endocrinol 144: 13–20

    Article  Google Scholar 

  3. de Ridder MA et al. (2007) Prediction of adult height in growth-hormone-treated children with growth hormone deficiency. J Clin Endocrinol Metab 92: 925–931

    Article  CAS  Google Scholar 

  4. Rosenbloom AL (1999) A mathematical model for predicting growth responses to growth hormone replacement therapy–a useful tool or an intellectual exercise? J Clin Endocrinol Metab 84: 1172–1173

    CAS  PubMed  Google Scholar 

  5. Cohen P et al. (2007) Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab 92: 2480–2486

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. 150 Lockwood Avenue, New Rochelle, NY 10801, USA phsaenger@aol.com

Authors and Affiliations

  1. P Saenger is a Professor of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USA.,

    Paul Saenger

Authors
  1. Paul Saenger
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

Dr Saenger is a consultant for Sandoz and a member of the Speaker's bureau for Eli Lilly, Genentech and Pfizer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saenger, P. Growth responses during the first year of growth hormone therapy: evaluation of height velocity targets. Nat Rev Endocrinol 4, 258–259 (2008). https://doi.org/10.1038/ncpendmet0792

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0792

  • Springer Nature Limited

Search

Navigation